Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection

被引:206
作者
Day, CL
Lauer, GM
Robbins, GK
McGovern, B
Wurcel, AG
Gandhi, RT
Chung, RT
Walker, BD
机构
[1] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Tufts Univ New England Med Ctr, Div Infect Dis, Boston, MA 02111 USA
[6] Lemuel Shattuck Hosp, Boston, MA USA
关键词
D O I
10.1128/JVI.76.24.12584-12595.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Vigorous virus-specific CD4(+) T-helper-cell responses are associated with successful control of hepatitis C virus (HCV) and other human viral infections, but the breadth and specificity of responses associated with viral containment have not been defined. To address this we evaluated the HCV-specific CD4(+) T-helper-cell response in HCV antibody-positive persons who lack detectable plasma viremia, and compared this response to that in persons with chronic HCV infection. Peripheral blood mononuclear cells were stimulated with HCV proteins, followed by measurement of HCV-specific CD4'-T-cell responses to a comprehensive set of overlapping HCV peptides by intracellular gamma interferon production. In three persons with resolved HCV infection studied in detail, 13 to 14 epitopes were targeted, but none was recognized by all three. The 37 defined epitopes were predominantly distributed among the HCV proteins core, NS3, NS4, and NS5. In an expanded analysis of responses to these proteins in persons with resolved infection, an average of 10 epitopes was targeted, whereas in persons with chronic viremia never was more than one epitope targeted (P < 0.001). This comprehensive analysis of the breadth and specificity of HCV-specific T-helper-cell responses indicates that up to 14 viral epitopes can be simultaneously targeted by circulating virus-specific CD4(+) T helper cells in a controlled human viral infection. Moreover, these data provide important parameters for evaluation of candidate HCV vaccines, and provide rationale for immunotherapy in chronic HCV infection.
引用
收藏
页码:12584 / 12595
页数:12
相关论文
共 54 条
  • [1] The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
    Alter, MJ
    Kruszon-Moran, D
    Nainan, OV
    McQuillan, GM
    Gao, FX
    Moyer, LA
    Kaslow, RA
    Margolis, HS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) : 556 - 562
  • [2] ENHANCED ESTABLISHMENT OF A VIRUS CARRIER STATE IN ADULT CD4+ T-CELL-DEFICIENT MICE
    BATTEGAY, M
    MOSKOPHIDIS, D
    RAHEMTULLA, A
    HENGARTNER, H
    MAK, TW
    ZINKERNAGEL, RM
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (07) : 4700 - 4704
  • [3] COMPREHENSIVE, SEROLOGICALLY EQUIVALENT DNA TYPING FOR HLA-B BY PCR USING SEQUENCE-SPECIFIC PRIMERS (PCR-SSP)
    BUNCE, M
    FANNING, GC
    WELSH, KI
    [J]. TISSUE ANTIGENS, 1995, 45 (02): : 81 - 90
  • [4] Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)
    Bunce, M
    ONeill, CM
    Barnardo, MCNM
    Krausa, P
    Browning, MJ
    Morris, PJ
    Welsh, KI
    [J]. TISSUE ANTIGENS, 1995, 46 (05): : 355 - 367
  • [5] Progressive loss of CD8(+) T cell-mediated control of a gamma-herpesvirus in the absence of CD4(+) T cells
    Cardin, RD
    Brooks, JW
    Sarawar, SR
    Doherty, PC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) : 863 - 871
  • [6] An ischemic stroke during intravenous recombinant tissue plasminogen activator infusion for evolving myocardial infarction
    Chang, GYN
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (03) : 267 - 268
  • [7] CD4+ T-cell-epitope escape mutant virus selected in vivo
    Ciurea, A
    Hunziker, L
    Martinic, MMA
    Oxenius, A
    Hengartner, H
    Zinkernagel, RM
    [J]. NATURE MEDICINE, 2001, 7 (07) : 795 - 800
  • [8] Impairment of CD4+ T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants
    Ciurea, A
    Hunziker, L
    Klenerman, P
    Hengartner, H
    Zinkernagel, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (03) : 297 - 305
  • [9] The scientific challenge of hepatitis C
    Cohen, J
    [J]. SCIENCE, 1999, 285 (5424) : 26 - 30
  • [10] Analysis of a successful immune response against hepatitis C virus
    Cooper, S
    Erickson, AL
    Adams, EJ
    Kansopon, J
    Weiner, AJ
    Chien, DY
    Houghton, M
    Parham, P
    Walker, CM
    [J]. IMMUNITY, 1999, 10 (04) : 439 - 449